BioPathNet: A New AI Tool for Analyzing Biomedical Data Networks
BioPathNet is an AI tool for analyzing biomedical data networks, aiding in gene functions and disease mechanisms. π§¬π
March 19, 2026
Follow us
latest articles
Discover the newest research about AI innovations in π§ͺ Drug Discovery.
Discovery of a novel compound against BmNPV using virtual screening based on the protein structure of the viral whole genome.
Novel antiviral compound identified against BmNPV using AI-driven virtual screening. Significant larval survival improvement observed. π¦π
March 15, 2026
DeepDegradome: A structure-aware deep learning framework for PROTAC and ligand generation against protein targets.
Revolutionary AI in Drug Design: DeepDegradome Enhances PROTAC Development with Higher Binding Affinity! ππ¬
March 13, 2026
MML-DTI: Multimanifold Learning with Hyperbolic Graph Neural Networks for Enhanced Drug-Target Interaction Prediction.
Revolutionary DTI prediction using hyperbolic geometry! π Enhanced accuracy through multimanifold learning and HGNN integration. π¬
March 10, 2026
Advances in Fragment-based Drug Design: Lessons and Innovations from the Post-COVID Drug Discovery Landscape.
Fragment-based drug design revolutionizes drug discovery, enhancing speed and efficiency post-COVID. Key insights from recent research. ππ¬
January 28, 2026
Artificial intelligence agents in cancer research and oncology.
AI agents revolutionizing cancer research: optimizing drug design, proposing therapies, and tackling complex challenges. π€π
January 13, 2026
A Multimodal Drug-Target Affinity Prediction Framework with Pretrained Models and Hierarchical Graph Transformer.
Revolutionary DTA Prediction: PMHGT-DTA Framework Enhances Drug Discovery with 3D Graphs and Cross-Attention! ππ¬
January 1, 2026
AI Enhances Monoclonal Antibody Development for Viral Infections
AI accelerates monoclonal antibody design, aiding in the fight against viral infections like RSV and avian influenza. π¦ π
December 21, 2025
Fungal virulence factors datasets for inflammatory bowel disease-specific antifungal drug discovery.
Fungal virulence factors dataset aids IBD antifungal drug discovery. 18,072 VFs identified; 390 potential VFs predicted. π¦ π
November 18, 2025
Technological advancements in antibody-based therapeutics for treatment of diseases.
Technological advancements in antibody therapeutics: 144 FDA-approved drugs, $267B sales, and AI-driven discoveries. ππ
November 13, 2025